These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19125216)

  • 1. Optimal use of antidepressants: when to act?
    Blier P
    J Psychiatry Neurosci; 2009 Jan; 34(1):80. PubMed ID: 19125216
    [No Abstract]   [Full Text] [Related]  

  • 2. Mirtazapine for depression in patients with human immunodeficiency virus.
    Elliott AJ; Roy-Byrne PP
    J Clin Psychopharmacol; 2000 Apr; 20(2):265-7. PubMed ID: 10770469
    [No Abstract]   [Full Text] [Related]  

  • 3. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression.
    Bech P
    Int J Neuropsychopharmacol; 2001 Dec; 4(4):337-45. PubMed ID: 11806859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mirtazapine: a review of its clinical efficacy and tolerability.
    Szegedi A; Schwertfeger N
    Expert Opin Pharmacother; 2005 Apr; 6(4):631-41. PubMed ID: 15934889
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional dyspepsia and mirtazapine.
    Lee SY; Rho SH; Choi SC
    Can J Psychiatry; 2002 Aug; 47(6):582-3. PubMed ID: 12211889
    [No Abstract]   [Full Text] [Related]  

  • 6. Sertraline- and mirtazapine-induced severe neutropenia.
    Ozcanli T; Unsalver B; Ozdemir S; Ozmen M
    Am J Psychiatry; 2005 Jul; 162(7):1386. PubMed ID: 15994730
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of mirtazapine on sleep in patients with major depressive disorder.
    Dolder CR; Nelson MH; Iler CA
    Ann Clin Psychiatry; 2012 Aug; 24(3):215-24. PubMed ID: 22860241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combining venlafaxine and mirtazapine for the treatment of major depression with dysthymia--"double depression"].
    Ladeira RB; Cunha FT; Salgado JV; Teixeira AL; Nicolato R
    Braz J Psychiatry; 2008 Sep; 30(3):299-300. PubMed ID: 18833439
    [No Abstract]   [Full Text] [Related]  

  • 9. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ; Stewart JW; Fava M; Trivedi MH; Wisniewski SR; Nierenberg AA; Thase ME; Davis L; Biggs MM; Shores-Wilson K; Luther JF; Niederehe G; Warden D; Rush AJ
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
    Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment-refractory depression successfully treated with the combination of mirtazapine and lithium.
    Moustgaard G
    J Clin Psychopharmacol; 2000 Apr; 20(2):268. PubMed ID: 10770470
    [No Abstract]   [Full Text] [Related]  

  • 12. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 13. Mirtazapine: a review of its use in major depression and other psychiatric disorders.
    Croom KF; Perry CM; Plosker GL
    CNS Drugs; 2009; 23(5):427-52. PubMed ID: 19453203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs.
    Fugger G; Bartova L; Fabbri C; Fanelli G; Zanardi R; Dold M; Kautzky A; Rujescu D; Souery D; Mendlewicz J; Zohar J; Montgomery S; Serretti A; Kasper S
    J Affect Disord; 2022 Sep; 312():225-234. PubMed ID: 35691416
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of pulmonary thromboembolism and rhabdomyolysis during therapy with mirtazapine and risperidone.
    Zink M; Knopf U; Argiriou S; Kuwilsky A
    J Clin Psychiatry; 2006 May; 67(5):835. PubMed ID: 16841636
    [No Abstract]   [Full Text] [Related]  

  • 16. Occurrence of mirtazapine-induced delirium in organic brain disorder.
    Bailer U; Fischer P; Küfferle B; Stastny J; Kasper S
    Int Clin Psychopharmacol; 2000 Jul; 15(4):239-43. PubMed ID: 10954066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
    Carpenter LL; Yasmin S; Price LH
    Biol Psychiatry; 2002 Jan; 51(2):183-8. PubMed ID: 11822997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute reversible dyskinesia induced by mirtazapine.
    Konitsiotis S; Pappa S; Mantas C; Mavreas V
    Mov Disord; 2005 Jun; 20(6):771. PubMed ID: 15732128
    [No Abstract]   [Full Text] [Related]  

  • 19. Flunarizine- and topiramate-associated depression responsive to mirtazapine.
    Bourgeois JA; Hategan A
    Psychosomatics; 2013; 54(5):503-4. PubMed ID: 24034532
    [No Abstract]   [Full Text] [Related]  

  • 20. Major depressive disorder, antidepressants, and sexual dysfunction.
    Clayton AH; Montejo AL
    J Clin Psychiatry; 2006; 67 Suppl 6():33-7. PubMed ID: 16848675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.